tiprankstipranks
Trending News
More News >
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market
Advertisement

Sarepta Therapeutics (SRPT) Technical Analysis

Compare
3,979 Followers

Technical Sentiment

Overall Consensus
Neutral
11Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is 0.41, suggesting Sarepta Therapeutics is a Sell.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 18.74, while Sarepta Therapeutics’s (SRPT) share price is $22.35, making it a Buy.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 19.85, while Sarepta Therapeutics’s (SRPT) share price is $22.35, making it a Buy.

Sarepta Therapeutics (SRPT) Pivot Points

Oct 03, 2025, 02:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.62
18.25
18.78
19.42
19.95
20.58
21.12
Fibonacci
18.25
18.70
18.97
19.42
19.86
20.13
20.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

Oct 03, 2025, 02:47 PM
Period
Simple
Exponential
MA5
19.62Buy
20.03Buy
MA10
18.81Buy
19.24Buy
MA20
18.29Buy
18.74Buy
MA50
18.07Buy
19.85Buy
MA100
22.88Sell
28.92Sell
MA200
58.05Sell
58.33Sell
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 19.24, while Sarepta Therapeutics’s (SRPT) share price is $22.35, making it a Buy.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 28.92, while Sarepta Therapeutics’s (SRPT) share price is $22.35, making it a Sell.
Sarepta Therapeutics’s (SRPT) stock price is $22.35 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 18.07, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $22.35 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 22.88, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) stock price is $22.35 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 58.05, creating a Sell signal.

Sarepta Therapeutics (SRPT) Technical Indicators

Oct 03, 2025, 02:47 PM
Name
Value
Implied Action
RSI (14)
67.73
Neutral
STOCH (9,6)
81.94
Sell
STOCHRSI (14)
83.67
Sell
MACD (12,26)
0.41
Sell
ADX (14)
13.83
Buy
Williams %R
-16.80
Sell
CCI (14)
355.80
Sell
ATR (14)
1.41
-
Ultimate Oscillator
61.42
Neutral
ROC
28.52
Buy
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 67.73, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 13.83, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is 355.80, creating a Sell signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is 28.52, creating a Buy signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Hold.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 67.73, which suggests SRPT is a Neutral.
      What is SRPT’s MACD?
      SRPT’s MACD is 0.41, which suggests SRPT is a Sell.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 19.62, which suggests SRPT is a Buy.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 18.29, which suggests SRPT is a Buy.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 18.07, which suggests SRPT is a Buy.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 58.05, which suggests SRPT is a Sell.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -16.80, which suggests SRPT is a Sell.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is 355.80, which suggests SRPT is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis